发明名称 PHTHALAZINONE DERIVATIVES
摘要 The use of a compound of the formula: and isomers, salts, solvates, chemical ly protected forms, and prodrugs thereof, in the preparation of a medicament fo r inhibiting the activity of PARP, wherein: A and B together represent an optionally substituted, fused aromatic ring; Rc is represented by -L-RL, whe re L is of formula: -(CH2)N1-QN2-(CH2)N3- wherein n1, n2 and n3 are each select ed from 0, 1, 2 and 3, the sum of n1, n2 and n3 is 1, 2 or 3 and Q is selected from O, S, NH or C(=O); and RL is an optionally substituted C5-20 aryl group ; and RN is selected from hydrogen, optionally substituted C1-7 alkyl, C3-20 heterocyclyl, and C5-20 aryl, hydroxy, ether, nitro, amino, amido, thiol, thioether, sulfoxide and sulfone. Novel compounds, and their use as pharmaceuticals, are also disclosed.
申请公布号 CA2423279(A1) 申请公布日期 2002.05.10
申请号 CA20012423279 申请日期 2001.10.25
申请人 KUDOS PHARMACEUTICALS LIMITED;MAYBRIDGE PLC 发明人 MARTIN, NIALL MORRISON BARR;VILE, JULIA;WHITE, CHARLES RICHARD;NEWTON, ROGER FRANK;DOUGLAS, DIANE GILLIAN;EVERSLEY, PENNY JANE;SMITH, GRAEME CAMERON MURRAY
分类号 C07D237/04;A61K31/50;A61K31/502;A61K31/5377;A61K31/541;A61P1/04;A61P9/00;A61P9/10;A61P25/00;A61P31/12;A61P31/20;A61P35/00;A61P43/00;C07D237/32;C07D401/12;C07D403/12;C07D405/12;C07D409/12;C07D409/14;C07D413/12;C07D417/12;C07D417/14;(IPC1-7):C07D237/32 主分类号 C07D237/04
代理机构 代理人
主权项
地址